Chinese Medicine Injection Qingkailing for Treatment of Acute Ischemia Stroke: A Systematic Review of Randomized Controlled Trials

Abstract EN

Qingkailing (QKL) injection was a famous traditional Chinese patent medicine, which was extensively used to treat the acute stages of cerebrovascular disease.

The aim of this study was to assess the quantity, quality and overall strength of the evidence on QKL in the treatment of acute ischemic stroke.

Methods.

An extensive search was performed within MEDLINE, Cochrane, CNKI, Vip and Wan-Fang up to November 2011.

Randomized controlled trails (RCTs) on QKL for treatment of acute stroke were collected, irrespective of languages.

Study selection, data extraction, quality assessment, and data analyses were conducted according to the Cochrane standards, and RevMan5 was used for data analysis.

Results.

7 RCTs (545 patients) were included and the methodological quality was evaluated as generally low.

The pooled results showed that QKL combined with conventional treatment was more effective in effect rate, and the score of MESSS and TNF-α level compared with conventional treatment alone, but there was no significant difference in mortality of two groups.

Only one trial reported routine life status.

There were four trials reported adverse events, and no obvious adverse event occurred in three trials while one reported adverse events described as eruption and dizziness.